Key result
PTRF expression in prostate cancer cells significantly decreased endothelial cell proliferation, migration, and differentiation in vitro, and reduced blood and lymphatic vessel densities in mice.
Why the study?
Does PTRF expression decrease angiogenesis and lymphangiogenesis in prostate cancer models?
Does PTRF expression decrease angiogenesis and lymphangiogenesis in prostate cancer models?
PTRF expression in prostate cancer cells inhibits angiogenesis and lymphangiogenesis, suggesting its loss contributes to tumor progression and metastasis.
Answers are grounded in this paper and cite their sources.
May limit prostate cancer angiogenesis; hypothesis-generating in animal models and leaves open human translation.
// Zeyad D. Nassar 1 , Hyeongsun Moon 2 , Tam Duong 3 , LiQi Neo 1 , Michelle M. Hill 2 , Mathias Francois 3 , Robert G. Parton 3 , Marie-Odile Parat 1 1 The University of Queensland, School of Pharmacy, QLD, Australia. 2 The University of Queensland Diamantina Institute, Translational Research Institute, QLD, Australia. 3 The University of Queensland, Institute for Molecular Bioscience, QLD, Australia. Correspondence: Marie-Odile Parat, email: // Keywords : PTRF, Caveolae, Angiogenesis, Lymphangiogenesis, Prostate Cancer Received : August 19, 2013 Accepted : October 1, 2013 Published : October 4, 2013 Abstract Caveolae are specialized plasma membrane subdomains implicated in cellular functions such as migration, signalling and trafficking. Caveolin-1 and polymerase I and transcript release factor (PTRF)/cavin-1 are essential for caveola formation. Caveolin-1 is overexpressed and secreted in prostate tumors and promotes aggressiveness and angiogenesis. In contrast, a lack of PTRF expression is reported in prostate cancer, and ectopic PTRF expression in prostate cancer cells inhibits tumor growth and metastasis. We experimentally manipulated PTRF expression in three prostate cancer cell lines, namely the caveolin-1 positive cells PC3 and DU145 and the caveolin-1-negative LNCaP cells, to evaluate angiogenesis- and lymphangiogenesis-regulating functions of PTRF. We show that the conditioned medium of PTRF-expressing prostate cancer cells decreases ECs proliferation, migration and differentiation in vitro and ex vivo . This can occur independently from caveolin-1 expression and secretion or caveola formation, since the anti-angiogenic effects of PTRF were detected in caveolin-1-negative LNCaP cells. Additionally, PTRF expression in PC3 cells significantly decreased blood and lymphatic vessel densities in orthotopic tumors in mice. Our results suggest that the absence of PTRF in prostate cancer cells contributes significantly to tumour progression and metastasis by promoting the angiogenesis and lymphangiogenesis potential of the cancer cells, and this could be exploited for therapy.
No takes yet. Share an insight, caveat, or question.
Nassar et al. (2013) studied Prostate Cancer. PTRF expression vs. Lack of PTRF expression was evaluated on Angiogenesis and lymphangiogenesis (endothelial cell proliferation, migration, differentiation, and vessel densities). PTRF expression in prostate cancer cells significantly decreased endothelial cell proliferation, migration, and differentiation in vitro, and reduced blood and lymphatic vessel densities in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: